PharmGen Science, Inc. (004720.KS)
KRW 4370.0
(-1.47%)
KRW 4370.0
(-1.47%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 335.91 Billion KRW | 5.84% |
| 2022 | 317.39 Billion KRW | 44.06% |
| 2021 | 220.32 Billion KRW | 62.55% |
| 2020 | 135.54 Billion KRW | 35.5% |
| 2019 | 100.03 Billion KRW | 1.88% |
| 2018 | 98.19 Billion KRW | 43.39% |
| 2017 | 68.48 Billion KRW | 6.5% |
| 2016 | 64.3 Billion KRW | 38.43% |
| 2015 | 46.44 Billion KRW | 10.48% |
| 2014 | 42.04 Billion KRW | 6.9% |
| 2013 | 39.32 Billion KRW | -7.71% |
| 2012 | 42.61 Billion KRW | -0.49% |
| 2011 | 42.82 Billion KRW | -19.78% |
| 2010 | 53.38 Billion KRW | -9.41% |
| 2009 | 58.92 Billion KRW | -33.53% |
| 2008 | 88.65 Billion KRW | 4.93% |
| 2007 | 84.48 Billion KRW | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 349.71 Billion KRW | 1.53% |
| 2024 Q1 | 344.44 Billion KRW | 2.54% |
| 2023 Q2 | 342.72 Billion KRW | 5.76% |
| 2023 Q3 | 343.11 Billion KRW | 0.11% |
| 2023 FY | 335.91 Billion KRW | 5.84% |
| 2023 Q1 | 324.05 Billion KRW | 2.1% |
| 2023 Q4 | 335.91 Billion KRW | -2.1% |
| 2022 Q3 | 338.26 Billion KRW | 5.35% |
| 2022 Q4 | 317.39 Billion KRW | -6.17% |
| 2022 FY | 317.39 Billion KRW | 44.06% |
| 2022 Q2 | 321.09 Billion KRW | 0.61% |
| 2022 Q1 | 319.16 Billion KRW | 44.86% |
| 2021 Q2 | 195.37 Billion KRW | 17.78% |
| 2021 Q4 | 220.32 Billion KRW | 7.72% |
| 2021 FY | 220.32 Billion KRW | 62.55% |
| 2021 Q3 | 204.52 Billion KRW | 4.68% |
| 2021 Q1 | 165.88 Billion KRW | 22.39% |
| 2020 FY | 135.54 Billion KRW | 35.5% |
| 2020 Q2 | 104.06 Billion KRW | 3.45% |
| 2020 Q1 | 100.59 Billion KRW | 0.56% |
| 2020 Q4 | 135.54 Billion KRW | 26.8% |
| 2020 Q3 | 106.89 Billion KRW | 2.72% |
| 2019 Q2 | 101.01 Billion KRW | 0.97% |
| 2019 FY | 100.03 Billion KRW | 1.88% |
| 2019 Q4 | 100.03 Billion KRW | 0.29% |
| 2019 Q3 | 99.74 Billion KRW | -1.25% |
| 2019 Q1 | 100.04 Billion KRW | 1.88% |
| 2018 Q3 | 74.05 Billion KRW | -2.05% |
| 2018 FY | 98.19 Billion KRW | 43.39% |
| 2018 Q1 | 71.13 Billion KRW | 3.88% |
| 2018 Q2 | 75.6 Billion KRW | 6.28% |
| 2018 Q4 | 98.19 Billion KRW | 32.6% |
| 2017 Q4 | 68.48 Billion KRW | 1.74% |
| 2017 FY | 68.48 Billion KRW | 6.5% |
| 2017 Q1 | 65.73 Billion KRW | 2.24% |
| 2017 Q2 | 63.9 Billion KRW | -2.79% |
| 2017 Q3 | 67.3 Billion KRW | 5.32% |
| 2016 Q2 | 60.52 Billion KRW | 0.8% |
| 2016 FY | 64.3 Billion KRW | 38.43% |
| 2016 Q3 | 61.58 Billion KRW | 1.76% |
| 2016 Q1 | 60.04 Billion KRW | 29.27% |
| 2016 Q4 | 64.3 Billion KRW | 4.4% |
| 2015 Q4 | 46.44 Billion KRW | 5.3% |
| 2015 Q3 | 44.11 Billion KRW | -4.12% |
| 2015 FY | 46.44 Billion KRW | 10.48% |
| 2015 Q1 | 43.8 Billion KRW | 4.18% |
| 2015 Q2 | 46 Billion KRW | 5.03% |
| 2014 Q3 | 41.93 Billion KRW | -3.37% |
| 2014 Q4 | 42.04 Billion KRW | 0.26% |
| 2014 Q2 | 43.39 Billion KRW | 15.09% |
| 2014 Q1 | 37.71 Billion KRW | -4.12% |
| 2014 FY | 42.04 Billion KRW | 6.9% |
| 2013 Q3 | 41.27 Billion KRW | -1.69% |
| 2013 FY | 39.32 Billion KRW | -7.71% |
| 2013 Q1 | 41.12 Billion KRW | -3.49% |
| 2013 Q2 | 41.98 Billion KRW | 2.08% |
| 2013 Q4 | 39.32 Billion KRW | -4.71% |
| 2012 Q2 | 41.94 Billion KRW | -6.13% |
| 2012 Q1 | 44.68 Billion KRW | 4.34% |
| 2012 FY | 42.61 Billion KRW | -0.49% |
| 2012 Q4 | 42.61 Billion KRW | -15.26% |
| 2012 Q3 | 50.28 Billion KRW | 19.89% |
| 2011 FY | 42.82 Billion KRW | -19.78% |
| 2011 Q2 | 49.06 Billion KRW | -18.3% |
| 2011 Q1 | 60.04 Billion KRW | 12.49% |
| 2011 Q4 | 42.82 Billion KRW | -4.14% |
| 2011 Q3 | 44.67 Billion KRW | -8.95% |
| 2010 FY | 53.38 Billion KRW | -9.41% |
| 2010 Q1 | 59.74 Billion KRW | 1.4% |
| 2010 Q2 | 60.6 Billion KRW | 1.44% |
| 2010 Q3 | 59.11 Billion KRW | -2.45% |
| 2010 Q4 | 53.38 Billion KRW | -9.7% |
| 2009 Q2 | 100.89 Billion KRW | 13.47% |
| 2009 Q1 | 88.91 Billion KRW | 0.3% |
| 2009 Q4 | 58.92 Billion KRW | -40.16% |
| 2009 Q3 | 98.47 Billion KRW | -2.4% |
| 2009 FY | 58.92 Billion KRW | -33.53% |
| 2008 Q3 | 94.73 Billion KRW | 5.55% |
| 2008 Q2 | 89.75 Billion KRW | 0.25% |
| 2008 FY | 88.65 Billion KRW | 4.93% |
| 2008 Q4 | 88.65 Billion KRW | -6.42% |
| 2008 Q1 | 89.53 Billion KRW | 5.97% |
| 2007 Q2 | 95.37 Billion KRW | 12.89% |
| 2007 Q4 | 84.48 Billion KRW | 2.58% |
| 2007 Q3 | 82.36 Billion KRW | -13.64% |
| 2007 FY | 84.48 Billion KRW | 0.0% |
| 2007 Q1 | 84.48 Billion KRW | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Daewoong Co., Ltd. | 2359.27 Billion KRW | 85.762% |
| Wooridul Huebrain Limited | 155.3 Billion KRW | -116.295% |